Related Experiment Video
Updated: Feb 15, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis
Mikkel Carstensen Gjelstrup1, Morten Stilund1,2, Thor Petersen2
1Department of Biomedicine, Aarhus University, Bartholin Building, Wilhelm Meyers Allé 4, DK-8000, Aarhus C, Denmark.
Abstract:
Multiple sclerosis (MS) is an immune mediated, inflammatory and demyelinating disease of the central nervous system (CNS). Substantial evidence points toward monocytes and macrophages playing prominent roles early in disease, mediating both pro- and anti-inflammatory responses. Monocytes are subdivided into three subsets depending on the expression of CD14 and CD16, representing different stages of inflammatory activation. To investigate their involvement in MS, peripheral blood mononuclear cells from 40 patients with incipient or progressed MS and 20 healthy controls were characterized ex vivo. In MS samples, we demonstrate a highly significant increase in nonclassical monocytes (CD14+CD16++), with a concomitant significant reduction in classical monocytes (CD14++CD16-) compared with healthy controls. Also, a significant reduction in the surface expression of CD40, CD163, and CD192 was found, attributable to the upregulation of the nonclassical monocytes. In addition, significantly increased levels of human endogenous retrovirus (HERV) envelope (Env) epitopes, encoded by both HERV-H/F and HERV-W, were specifically found on nonclassical monocytes from patients with MS; emphasizing their involvement in MS disease. In parallel, serum and cerebrospinal fluid (CSF) samples were analyzed for soluble biomarkers of inflammation and neurodegeneration. For sCD163 versus CD163, no significant correlations were found, whereas highly significant correlations between levels of soluble neopterine and the intermediate monocyte (CD14++CD16+) population was found, as were correlations between levels of soluble osteopontin and the HERV Env expression on nonclassical monocytes. The results from this study emphasize the relevance of further focus on monocyte subsets, particularly the nonclassical monocytes in monitoring of inflammatory diseases.
Insights
Nonclassical monocytes increase in multiple sclerosis (MS), a central nervous system (CNS) disease, correlating with human endogenous retrovirus (HERV) expression. This highlights nonclassical monocytes as key biomarkers for monitoring MS inflammation.
Area of Science:
- Neuroimmunology
- Immunology
- Cellular Biology
Background:
- Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the central nervous system (CNS).
- Monocytes and macrophages are implicated in MS pathogenesis, exhibiting both pro- and anti-inflammatory functions.
- Monocytes are classified into subsets (classical, intermediate, nonclassical) based on CD14 and CD16 expression, reflecting inflammatory activation states.
Purpose of the Study:
- To investigate the role of distinct monocyte subsets in multiple sclerosis (MS).
- To analyze the expression of specific cell surface markers and human endogenous retrovirus (HERV) epitopes on monocyte subsets in MS patients.
- To correlate soluble biomarkers in serum and cerebrospinal fluid (CSF) with monocyte populations and HERV expression in MS.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from 40 MS patients and 20 healthy controls were analyzed ex vivo.
- Monocyte subsets (classical, intermediate, nonclassical) were identified using CD14 and CD16 surface marker expression.
- Flow cytometry was used to quantify cell surface markers (CD40, CD163, CD192) and HERV envelope (Env) epitopes on monocyte subsets.
- Serum and CSF samples were analyzed for soluble biomarkers including sCD163, neopterin, and osteopontin.
Main Results:
- A significant increase in nonclassical monocytes (CD14+CD16++) and a decrease in classical monocytes (CD14++CD16-) were observed in MS patients compared to controls.
- Reduced surface expression of CD40, CD163, and CD192 was noted on nonclassical monocytes in MS.
- Elevated levels of HERV Env epitopes were specifically found on nonclassical monocytes from MS patients.
- Significant correlations were found between soluble neopterin and intermediate monocytes, and between soluble osteopontin and HERV Env expression on nonclassical monocytes.
Conclusions:
- Nonclassical monocytes are significantly upregulated in MS and are associated with increased HERV Env expression.
- The findings underscore the critical role of monocyte subsets, particularly nonclassical monocytes, in MS pathogenesis.
- Nonclassical monocytes and associated biomarkers may serve as valuable targets for monitoring inflammation in MS.
Related Concept Videos
Inflammation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Multiple Allele Traits
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...

